Pembrolizumab-Associated Stevens-Johnson Syndrome in a Patient With Metastatic Non-small Cell Lung Cancer: A Case Report

Pembrolizumab is a monoclonal antibody that binds to the programmed cell death-1 (PD-1) receptor and is approved for the treatment of several malignancies. We present a rare case of Stevens-Johnson syndrome (SJS) occurring in a 75-year-old female 14 days after receiving the first dose of pembrolizum...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandhu, Michael, KC, Binod, Bhandari, Jenish, Gambhir, Harvir S, Farah, Ramsay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403812/
https://www.ncbi.nlm.nih.gov/pubmed/37546048
http://dx.doi.org/10.7759/cureus.41439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10403812/
https://www.ncbi.nlm.nih.gov/pubmed/37546048
http://dx.doi.org/10.7759/cureus.41439

Ejemplares similares